Skip to main content
Top
Published in: Critical Care 1/2020

01-12-2020 | Letter

Who may benefit most from future vitamin D intervention trials: do not forget patients on continuous renal replacement therapy

Authors: Patrick M. Honore, Aude Mugisha, Luc Kugener, Sebastien Redant, Rachid Attou, Andrea Gallerani, David De Bels

Published in: Critical Care | Issue 1/2020

Login to get access

Excerpt

We read with great interest the recent paper by Martucci et al. who concluded that high-dose vitamin D3 supplementation was associated with a reduction in 28-day mortality in a mixed population of critically ill adults with vitamin D deficiency [1]. Their analysis also attempted to identify who may benefit the most from future vitamin D intervention trials [1]. We would like to make some comments. In their paper, Martucci et al. did not include data regarding patients with acute kidney injury (AKI) needing renal replacement therapy (RRT) within the critically ill population they studied [1]. …
Literature
2.
go back to reference Honoré PM, De Waele E, Jacobs R, Mattens S, Rose T, Joannes-Boyau O, De Regt J, Verfaillie L, Van Gorp V, Boer W, Collin V, Spapen HD. Nutritional and metabolic alterations during continuous renal replacement therapy. Blood Purif. 2013;35(4):279–84. https://doi.org/10.1159/000350610 Epub 2013 May 8. Review..CrossRefPubMed Honoré PM, De Waele E, Jacobs R, Mattens S, Rose T, Joannes-Boyau O, De Regt J, Verfaillie L, Van Gorp V, Boer W, Collin V, Spapen HD. Nutritional and metabolic alterations during continuous renal replacement therapy. Blood Purif. 2013;35(4):279–84. https://​doi.​org/​10.​1159/​000350610 Epub 2013 May 8. Review..CrossRefPubMed
6.
go back to reference Vincent JL, Marini JJ, Pesenti A. Do trials that report a neutral or negative treatment effect improve the care of critically ill patients? No. Intensive Care Med. 2018;44(11):1989–91..CrossRef Vincent JL, Marini JJ, Pesenti A. Do trials that report a neutral or negative treatment effect improve the care of critically ill patients? No. Intensive Care Med. 2018;44(11):1989–91..CrossRef
7.
go back to reference Martucci G, McNally D, Parekh D, Zajic P, Tuzzolino F, Arcadipane A, Christopher KB, Dobnig H, Amrein K. Trying to identify who may benefit most from future vitamin D intervention trials: a post hoc analysis from the VITDAL-ICU study excluding the early deaths. Crit Care (London, England). 2019;23(1):200..CrossRef Martucci G, McNally D, Parekh D, Zajic P, Tuzzolino F, Arcadipane A, Christopher KB, Dobnig H, Amrein K. Trying to identify who may benefit most from future vitamin D intervention trials: a post hoc analysis from the VITDAL-ICU study excluding the early deaths. Crit Care (London, England). 2019;23(1):200..CrossRef
8.
go back to reference Amrein K, Martucci G, McNally JD, et al. Clin Nutr (Edinburgh, Scotland). 2017;36(6):1729–30..CrossRef Amrein K, Martucci G, McNally JD, et al. Clin Nutr (Edinburgh, Scotland). 2017;36(6):1729–30..CrossRef
9.
go back to reference Amrein K, Schnedl C, Holl A, Riedl R, Christopher KB, Pachler C, Urbanic Purkart T, Waltensdorfer A, Munch A, Warnkross H, et al. Effect of high-dose vitamin D3 on hospital length of stay in critically ill patients with vitamin D deficiency: the VITdAL-ICU randomized clinical trial. JAMA. 2014;312(15):1520–30..CrossRef Amrein K, Schnedl C, Holl A, Riedl R, Christopher KB, Pachler C, Urbanic Purkart T, Waltensdorfer A, Munch A, Warnkross H, et al. Effect of high-dose vitamin D3 on hospital length of stay in critically ill patients with vitamin D deficiency: the VITdAL-ICU randomized clinical trial. JAMA. 2014;312(15):1520–30..CrossRef
10.
go back to reference Zajic P, Heschl S, Schörghuber M, Srekl-Filzmaier P, Stojakovic T, Weixler V, Zelzer S, Amrein K. Vitamin D assessment in perioperative medicine and critical care: A prospective observational pilot study. Wien Klin Wochenschr. 2019. https://doi.org/10.1007/s00508-019-01584-x. [Epub ahead of print]. Zajic P, Heschl S, Schörghuber M, Srekl-Filzmaier P, Stojakovic T, Weixler V, Zelzer S, Amrein K. Vitamin D assessment in perioperative medicine and critical care: A prospective observational pilot study. Wien Klin Wochenschr. 2019. https://​doi.​org/​10.​1007/​s00508-019-01584-x. [Epub ahead of print].
11.
12.
go back to reference Lefler DM, Pafford RG, Black NA, Raymond JR, Arthur JM. Identification of proteins in slow continuous ultrafiltrate by reversed-phase chromatography and proteomics. J Proteome Res. 2004;3(6):1254–60..CrossRef Lefler DM, Pafford RG, Black NA, Raymond JR, Arthur JM. Identification of proteins in slow continuous ultrafiltrate by reversed-phase chromatography and proteomics. J Proteome Res. 2004;3(6):1254–60..CrossRef
13.
go back to reference Amrein K, Parekh D, Westphal S, Preiser JC, Berghold A, Riedl R, Eller P, Schellongowski P, Thickett D, Meybohm P. Effect of high-dose vitamin D3 on 28-day mortality in adult critically ill patients with severe vitamin D deficiency: a study protocol of a multicentre, placebo-controlled double-blind phase III RCT (the VITDALIZE study). BMJ Open. 2019;9(11):e031083..CrossRef Amrein K, Parekh D, Westphal S, Preiser JC, Berghold A, Riedl R, Eller P, Schellongowski P, Thickett D, Meybohm P. Effect of high-dose vitamin D3 on 28-day mortality in adult critically ill patients with severe vitamin D deficiency: a study protocol of a multicentre, placebo-controlled double-blind phase III RCT (the VITDALIZE study). BMJ Open. 2019;9(11):e031083..CrossRef
Metadata
Title
Who may benefit most from future vitamin D intervention trials: do not forget patients on continuous renal replacement therapy
Authors
Patrick M. Honore
Aude Mugisha
Luc Kugener
Sebastien Redant
Rachid Attou
Andrea Gallerani
David De Bels
Publication date
01-12-2020
Publisher
BioMed Central
Published in
Critical Care / Issue 1/2020
Electronic ISSN: 1364-8535
DOI
https://doi.org/10.1186/s13054-020-02910-w

Other articles of this Issue 1/2020

Critical Care 1/2020 Go to the issue